Optimal use, combinations, and sequencing of therapies in advanced prostate cancer

Clayton K. Oakley, Benjamin A. Teply

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)13-16
Number of pages4
JournalExpert Review of Clinical Pharmacology
Volume18
Issue number1-2
DOIs
StatePublished - 2025

Keywords

  • PARP inhibitors
  • Prostate cancer
  • metastatic
  • novel hormone therapy
  • radiopharmaceuticals
  • sequencing therapies

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • Pharmacology (medical)

Cite this